ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+16.9%
5Y CAGR+22.5%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
+16.9%/yr
vs +14.5%/yr prior
5Y CAGR
+22.5%/yr
Recent deceleration
Acceleration
+2.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $540.72M | +26.2% |
| 2024 | $428.53M | -6.4% |
| 2023 | $457.60M | +35.2% |
| 2022 | $338.54M | -5.6% |
| 2021 | $358.74M | +83.3% |
| 2020 | $195.70M | -8.0% |
| 2019 | $212.79M | +7.9% |
| 2018 | $197.26M | +12.9% |
| 2017 | $174.76M | +3.0% |
| 2016 | $169.65M | - |